Beaulieu Joseph
- SEC CIK
- 0001766032
No open-market purchases or sales filed in the past year.
Current role at each company
- EPZM Epizyme, Inc.See Remarksas of Aug 16, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Beaulieu Joseph as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Beaulieu JosephCorporate Controller | SSaleCommon Stock, par value $0.0001 | −222 | $1.50 | −$333 | −0.8%28.6K after | |
| Feb 4, 2022 (view filing) | Feb 2 | 2 days | Beaulieu JosephCorporate Controller | SSaleCommon Stock, par value $0.0001 | −687 | $1.37 | −$941.19 | −2.3%28.9K after |